Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer

다국어 초록 (Multilingual Abstract)

Objective: Since there have been few large series studies to date, we investigated the relationship between Trousseau's syndrome associated with cerebral infarction and its clinical associations with ovarian cancer.
Methods: In this study, we investigated the association between cerebral infarction onset and ovarian cancer. Eight-hundred twenty-seven consecutive ovarian cancer patients from 4 affiliated academic institutions were included in the study over a 12 years period. All patients were histopathologically diagnosed as epithelial ovarian cancer and were analyzed retrospectively.
Results: The 27 patients (3.2%) presented with cerebral infarction during the study period, 14 patients onset prior to treatment (1.7%), and 13 patients onset after start of initial treatment (1.5%). Univariate analysis and multivariate analysis was performed for onset of Trousseau's syndrome and various clinical and pathological parameters. There was no statistical significance between the occurrence of Trousseau's syndrome with age or International Federation of Gynecology and Obstetrics (FIGO) stage; however, univariate analysis and multivariate analysis demonstrated a statistically significant association between clear cell carcinoma (CCC) and non-CCC histology.
Conclusion: Thus, our results demonstrate that Trousseau's syndrome with cerebral infarction occurred with greater incidence among CCC cases compared to non-CCC cases.

참고문헌 (Reference)

1 이혜경, "대학생 그룹 멘토링 프로그램의 효과성 측정을 위한 멘토역량 척도 개발 연구 - 대학생 그룹 멘토 참여자를 대상으로 -" 한국청소년학회 19 (19): 61-87, 2012

2 Duska LR, "When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes" 116 : 374-377, 2010

3 Rodriguez AO, "Venous thromboembolism in ovarian cancer" 105 : 784-790, 2007

4 Diaz ES, "Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival" 131 : 541-545, 2013

5 Ikushima S, "Trousseau's syndrome: cancer-associated thrombosis" 46 : 204-208, 2016

6 Sorensen HT, "The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism" 338 : 1169-1173, 1998

7 Sack GH JrLevin J, "Rousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features" 56 : 1-37, 1977

8 Levitan N, "Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data" 78 : 285-291, 1999

9 Tateo S, "Ovarian cancer and venous thromboembolic risk" 99 : 119-125, 2005

10 Recio FO, "Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy" 78 : 2157-2163, 1996

11 Wataru Yamagami, "Clinical statistics of gynecologic cancers in Japan" 대한부인종양학회 28 (28): 1-13, 2017

12 Yoonessi M, "Clear cell ovarian adenocarcinoma" 27 : 289-297, 1984

13 Goff BA, "Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease" 60 : 412-417, 1996